You have no items in your shopping cart.
Cardiac safety is the number one cause of trial delay and drug abandonment. As the most trusted name in cardiac safety, ERT uses a centralized approach to collection. Our data tools are rigorous, responsive, and accountable. So, you can feel assured that high-quality data drives your decisions.
ERT’s eCOA and dedicated vaccines eDiary solutions deliver high-quality, regulatory-compliant data, fast. Take a look at the videos below to learn more.
Receive precise and cost-effective QT assessments with Early Precision QT (EPQT). Having these higher-level insights in your hands sooner benefits you. Specifically, you can save millions and potentially qualify for a TQT waiver.
Avoid safety and regulatory issues long before they become critical with strategic protocol and study design for early- and late-phase studies. Our consulting team can also help you determine the best devices and integrated solution and select the best strategy for analyzing cardiac safety.
Ensure your study has the right patients by opting for Rapid ECG, our alert service to analyze screening and other ECGs. As the only central lab to offer this service, experts will analyze screening and other ECGs in digital format within 4 hours before the inclusion/exclusion decision is made and while the patient is at the site.
Confidently navigate unexpected issues throughout your trial by collaborating with our Phase 1 Center of Excellence and working with highly-trained and qualified sites.
Standardized Holter ECG collection devices provide identical algorithms and transmission to a central database.
Our experts can assist you in navigating regulatory changes and implementing the right blood pressure monitoring method or methods for your trial, including ambulatory blood pressure monitoring, clinic blood pressure monitoring, and more.
When every millisecond of precision counts, confidently navigate cardiac safety assessments in your early-phase trial to support protocol compliance, improve data quality, reduce investigator workload and shorten time-to-market.
NextbridgeX is the leading global source for identifying, procuring and managing the delivery of clinical research product and services.
Copyright © 2022 Nextbridge Health Inc. All rights reserved.